Literature DB >> 9737523

Ischemic preconditioning in pigs: a graded phenomenon: its relation to adenosine and bradykinin.

R Schulz1, H Post, C Vahlhaus, G Heusch.   

Abstract

BACKGROUND: A threshold concept for ischemic preconditioning (IPc) has been proposed. It is unclear, however, whether IPc, above a certain threshold, is an all-or-nothing or a graded phenomenon. METHODS AND
RESULTS: In 71 enflurane-anesthetized swine, severe left anterior descending coronary artery hypoperfusion for 90 minutes followed by 2 hours of reperfusion resulted in an infarct size (IS, by triphenyltetrazolium chloride) of 16.7+/-3.4% (SEM) of the area at risk. IPc by 2 minutes of low-flow ischemia and 15 minutes of reperfusion before the 90-minute target ischemia did not reduce IS (21.9+/-7.0%). IS was decreased to 9.0+/-2.6% (P<0.05) by 3 minutes of IPc and reduced further to 1.9+/-0.9% (P<0.05) by 10 minutes of IPc. The interstitial adenosine concentration (microdialysis, high-performance liquid chromatography) was unchanged with 2 and 3 minutes of IPc but increased with 10 minutes of IPc (by 573+/-144%). The interstitial bradykinin concentration (microdialysis, radioimmunoassay) remained unchanged with 2 minutes of IPc but increased to a similar extent with 3 minutes (by 198+/-32%) and 10 minutes (by 224+/-30%) of IPc. The IS reduction by 3 minutes of IPc was abolished by blockade of the bradykinin B2 receptor with intracoronary HOE 140 (16.6+/-4.3%) but not with intracoronary infusion of adenosine deaminase (8.4+/-2.5%, P<0.05). HOE 140, however, did not affect the IS reduction (3.5+/- 1.1%, P<0.05) by 10 minutes of IPc. Combined infusion of HOE 140 and adenosine deaminase abolished the IS reduction by 10 minutes of IPc (15.4+/-6.7%).
CONCLUSIONS: IS reduction by IPc is a graded phenomenon. Whereas bradykinin is essential during preconditioning ischemia of shorter duration, adenosine is more important during preconditioning ischemia of longer duration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737523     DOI: 10.1161/01.cir.98.10.1022

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  32 in total

Review 1.  Role of bradykinin in preconditioning and protection of the ischaemic myocardium.

Authors:  G F Baxter; Z Ebrahim
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

2.  Enhanced reduction of myocardial infarct size by combined ACE inhibition and AT(1)-receptor antagonism.

Authors:  R Weidenbach; R Schulz; P Gres; M Behrends; H Post; G Heusch
Journal:  Br J Pharmacol       Date:  2000-09       Impact factor: 8.739

3.  Activation of ATP-dependent potassium channels is a trigger but not a mediator of ischaemic preconditioning in pigs.

Authors:  Rainer Schulz; Petra Gres; Gerd Heusch
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

Review 4.  Mechanism of cardioprotection by early ischemic preconditioning.

Authors:  Xiulan Yang; Michael V Cohen; James M Downey
Journal:  Cardiovasc Drugs Ther       Date:  2010-06       Impact factor: 3.727

Review 5.  Organ preconditioning: the past, current status, and related lung studies.

Authors:  Shi-ping Luh; Pan-chyr Yang
Journal:  J Zhejiang Univ Sci B       Date:  2006-05       Impact factor: 3.066

6.  A kallidin-like peptide is a protective cardiac kinin, released by ischaemic preconditioning of rat heart.

Authors:  Xiuxin Liu; Martina Lukasova; Radka Zubakova; Sabina Lewicka; Ulrich Hilgenfeldt
Journal:  Br J Pharmacol       Date:  2005-12       Impact factor: 8.739

Review 7.  Therapeutic receptor targets of ischemic preconditioning.

Authors:  Ryan M Fryer; John A Auchampach; Garrett J Gross
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

Review 8.  Optimising exercise training in peripheral arterial disease.

Authors:  Andrew C Bulmer; Jeff S Coombes
Journal:  Sports Med       Date:  2004       Impact factor: 11.136

9.  An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques.

Authors:  Andreas Schuster; Inga Grünwald; Amedeo Chiribiri; Richard Southworth; Masaki Ishida; Gunnar Hay; Nicole Neumann; Geraint Morton; Divaka Perera; Tobias Schaeffter; Eike Nagel
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-17       Impact factor: 5.364

10.  Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

Authors:  Hideki Ishii; Tetsuya Amano; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.